The chemotherapy drugs cisplatin and carboplatin have become difficult for hospital systems across the country to access in recent months, disrupting cancer treatments and leading health care providers and patients to worry about the future. According to the Society of Gynecologic Oncology, platinum drug shortages, including cisplatin and carboplatin, were